HERPES SIMPLEX PLUS National Drug Code Directory

Similar documents
SODIUM BICARBONATE National Drug Code Directory

POTASSIUM CITRATE CITRIC ACID CRYSTALS National Drug Code Directory

PHENYTOIN SODIUM National Drug Code Directory

ADRENAL SUPPORT National Drug Code Directory

MYCAMINE National Drug Code Directory

DIVALPROEX SODIUM National Drug Code Directory

DEXAMETHASONE SODIUM PHOSPHATE National Drug Code Directory

MORPHINE SULFATE National Drug Code Directory

HAVRIX National Drug Code Directory

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE 20/5/12.5 MG National Drug Code Directory

CITRANATAL DHA National Drug Code Directory

SHEER COVER MINERAL FOUNDATION National Drug Code Directory

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE National Drug Code Directory

ANTICOAGULANT CITRATE DEXTROSE A ACD-A National Drug Code Directory

SUBSYS National Drug Code Directory

PRIMAXIN National Drug Code Directory

LYMPH/SPLEEN COMBO National Drug Code Directory

FLUZONE QUADRIVALENT National Drug Code Directory

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE National Drug Code Directory

National Drug Code Directory

KETAMINE HYDROCHLORIDE National Drug Code Directory

DIANEAL LOW CALCIUM WITH DEXTROSE National Drug Code Directory

BUG BITES - ITCH STOPPER National Drug Code Directory

FLUZONE INTRADERMAL QUADRIVALENT National Drug Code Directory

THYRO T3 RESCUE National Drug Code Directory

National Drug Code Directory

TRANQUIL REMEDY NO. 11 National Drug Code Directory

FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE) National Drug Code Directory

O-CAL FA MULTIVITAMIN National Drug Code Directory

National Drug Code Directory

PEDIATRIC INFUVITE MULTIPLE VITAMINS FOR INFUSION National Drug Code Directory

CALM REMEDY WATER National Drug Code Directory

DAPTACEL National Drug Code Directory

National Drug Code Directory

FOLET DHA National Drug Code Directory

CLEANSE REMEDY WATER National Drug Code Directory

INTRODUCTION 1. DERMATOLOGY

Guidance for Industry

Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Physician Injectable Drug List (PIDL) Department for Medicaid Services, HP, and Magellan Rx Management June 1, 2010

Calcium Folinate Solution for Injection

Prednisolone Sodium Phosphate Ophthalmic Solution USP, 1% (Sterile) Rx only

Inspections, Compliance, Enforcement, and Criminal Investigations

Inviting Quotations for Supply of Homeopathic medicine for Department of Homoeopathy, AIIMS Raipur QUOTATION NOTICE

Muzumdar Cynodon Dactylon and its Proving

Making Homeopathic Remedies Handout

CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY

Brand and Generic Drugs. Educational Objectives. Absorption

Mark M. Yacura. Partner

Three-Month Extension of Certain Tobacco Product Compliance Deadlines Related to the

ANDA Labeling Question Based Review September 11, 2013 GPhA/FDA ANDA Labeling Workshop/USP User Forum

Teva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs 425 Privet Road Horsham, PA 19044

Lamivudine Tablets 150 mg (Macleods Pharmaceuticals Ltd), HA424. WHOPAR Part 5 05/2011, version 1.0 LABELLING. Page 1 of 8

Research paper. Compensated model of the homeopathic repertory. version 1.0

Inspections, Compliance, Enforcement, and Criminal Investigations

NDA NDA APPROVAL

Similarity & Difference in OTC Classification and their Borderlines among Asia Pacific

CENTER FOR DRUG EVALUATION AND RESEARCH. APPLICATION NUMBER: Orig1s000 APPROVAL LETTER

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Naloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan

Harmonization effort for OTC monograph in Taiwan. Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA

International Pharmaceutical Aerosol Consortium on Regulation and Science

The State Pharmacopoeia of the Russian Federation

4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch

RE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements

ORANGE BOOK ORANGE BOOK

Cotter T. / Cotter E. L. Homeopathy in the Curing of Cancer

Guideline on the Regulation of Therapeutic Products in New Zealand

Science IN THE Public Interest ) ihr nonprofit puhliihc~?/ Nutrition Action FIea!thIcttcr

ANDA Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY December 3, 2015

SOMNUS VITM Supplement for sleep and wellness

USP Perspective on Atypical Actives November 29, 2017

4.5.2 Children with diarrhoea

Second BHMS Materia Medica Question Papers Calicut University

FDA Laws & Pharmacy Practice

Compare Results. 153 Replacements 26 Insertions 344 Deletions. Total Changes. Styling and. Content. 0 Annotations. Old File: New File:

2 Mylan Valsartan/Combination Class 2 Recall

DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f

Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution)

Agenda. The current state of Pharmaceutical Excipients in Japan -JPE, JP, DMF, GAB (GMP Auditing Board)- Pharmaceutical Excipients

Daniel Fabricant, Ph.D

BAYER ADVANCED ASPIRIN REGULAR STRENGTH-

SAFETY DATA SHEETS. This SDS packet was issued with item: N/A

Reference Guide Contents

TABLE OF CONTENTS. The Remedies 17 Rare Remedies and Polychrests 17

FDA Laws & Pharmacy Practice

SUMMARY: The Food and Drug Administration (FDA) is requesting public input on updated

SNuVASivE: 51. 0(k) Premarket Notification Long Lateral Spinal System

Materia Medica at A Glance

HEDIS 2018 Medications List Directory User Manual

Artesunate/amodiaquine 100/270 mg WHOPAR part 5 03/2009, version 1.0 (Sanofi-Aventis) MA058 LABELING

Transcription:

43742-1047-1 HERPES SIMPLEX PLUS The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs manufactured, prepared, propagated, compounded, or processed by it for commercial distribution. (See Section 510 of the Federal Food, Drug, and Cosmetic Act (Act) (21 U.S.C. 360)). Drug products are identified and reported using a unique, three-segment number, called the National Drug Code (NDC), which serves as a universal product identifier for drugs. FDA publishes the listed NDC numbers and the information submitted as part of the listing information in the NDC Directory which is updated daily. 2019

43742-1047-1 Herpes Simplex Plus Labeler Deseret Biologicals,Inc. of Company corresponding to the labeler code segment of the ProductNDC. NDC Package Code 43742-1047-1 The labeler code, product code, and package code segments of the National Drug Code number, separated by hyphens. Asterisks are no longer used or included within the product and package code segments to indicate certain configurations of the NDC. Proprietary Herpes Simplex Plus Also known as the trade name. It is the name of the product chosen by the labeler. 11 Digit NDC Code 43742-1047-01 It should be noted that many NDCs are displayed on drug packaging in a 10-digit format. Proper billing of an NDC requires an 11-digit number in a 5-4-2 format. Converting NDCs from a 10-digit to 11-digit format requires a strategically placed zero, dependent upon the 10-digit format. Product NDC 43742-1047 The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. Product Type Non Proprietary Package Description Marketing Category HUMAN OTC DRUG Allium Sativum, Calendula Officinalis, Sambucus Nigra, Clematis Erecta, Dulcamara, Petroleum, Sarsaparilla (smilax Regelii), Graphites, Arsenicum Album, Croton Tiglium, Mercurius Sulphuratus Ruber, Natrum Muriaticum, Nitricum Acidum, Rhus Tox, Sepia, Thuja Occidentalis 30 ml in 1 BOTTLE, DROPPER (43742-1047- 1) UNAPPROVED HOMEOPATHIC Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the Document Type of the SPL submission for the listing. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. Sometimes called the generic name, this is usually the active ingredient(s) of the product. A description of the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. For example: 4 BOTTLES in 1 CARTON/100 TABLETS in 1 BOTTLE. Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. - 2 -

Product Marketing Start Date 20170731 This is the date that the labeler indicates was the start of its marketing of the drug product. Dosage Form LIQUID The translation of the DosageForm Code submitted by the firm. The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. Route ORAL The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. Substance Strength Number Strength Unit GARLIC; CALENDULA OFFICINALIS FLOWERING TOP; SAMBUCUS NIGRA FLOWERING TOP; CLEMATIS RECTA FLOWERING TOP; SOLANUM DULCAMARA TOP; KEROSENE; SMILAX ORNATA ROOT; GRAPHITE; ARSENIC TRIOXIDE; CROTON TIGLIUM SEED; MERCURIC SULFIDE; SODIUM CHLORIDE; NITRIC ACID; TOXICODENDRON PUBESCENS LEAF; SEPIA OFFICINALIS JUICE; THUJA OCCIDENTALIS LEAFY TWIG 2; 2; 3; 6; 6; 6; 6; 8; 12; 12; 12; 12; 12; 12; 12; 12 [hp_x]/ml; [hp_x]/ml This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. These are the strength values (to be used with units below) of each active ingredient, listed in the same order as the Substance field above. These are the units to be used with the strength values above, listed in the same order as the Substance and SubstanceNumber. - 3 -

Status Active NDC Code Status: <ul> <li><strong>active</strong> <br/>active NDC Code</li> <li><strong>deprecated</strong> <br/>deprecated NDC Code</li> <li> <strong>unfinished</strong> (Unapproved) <br/>the following status describes submitted unfinished drugs, including the marketing categories of Active Pharmaceutical Ingredient (API), Drug for Further Processing, Bulk for Human Drug Compounding, and Bulk for Animal Drug Compounding. <br/> <strong> FDA does not review and approve unfinished products. Therefore, all products having "unfinished" status are considered unapproved. </strong> </li> </ul> Last Update Date 2017-08-02 The date that a record was last updated or changed. - 4 -

Food and Drug Administration Center for Drug Evaluation and Research Office of Compliance, Immediate Office Drug Registration and Listing Team 10903 New Hampshire Ave Silver Spring, MD 20993-0002 Email: edrls@fda.hhs.gov - 5 -

For all questions regarding this bundle please contact Support@HIPAASpace.com. Also feel free to let us know about any suggestions or concerns. All additional information as well as customer support is available at http://. - 6 -